Details for New Drug Application (NDA): 212319
✉ Email this page to a colleague
The generic ingredient in ATROPINE (AUTOINJECTOR) is atropine. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the atropine profile page.
Summary for 212319
Tradename: | ATROPINE (AUTOINJECTOR) |
Applicant: | Rafa Labs Ltd |
Ingredient: | atropine |
Patents: | 0 |
Pharmacology for NDA: 212319
Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for 212319
Suppliers and Packaging for NDA: 212319
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATROPINE (AUTOINJECTOR) | atropine | SOLUTION;INTRAMUSCULAR | 212319 | NDA | Rafa Laboratories, Ltd. | 71053-592 | 71053-592-01 | 480 CARTON in 1 BOX (71053-592-01) / 40 SYRINGE in 1 CARTON / .7 mL in 1 SYRINGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAMUSCULAR | Strength | EQ 2MG SULFATE/0.7ML (EQ 2MG SULFATE/0.7ML) | ||||
Approval Date: | Jul 9, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription